'0 patients' diaporamas de présentation

New Evidence reports on presentations given at ASH 2009

New Evidence reports on presentations given at ASH 2009. Improving Response to Treatment in CLL with the Addition of Rituximab and Alemtuzumab to Chemoimmunotherapy. From ASH 2009 : Chronic Lymphocytic Leukemia.

634 views • 50 slides

New Drugs and New Strategies from the 2014 CROI

New Drugs and New Strategies from the 2014 CROI. Jeffrey Lennox, MD Co-PI, Emory HIV/AIDS Clinical Trials Unit. Learning Objectives. After attending this presentation, learners will be able to:. Describe the antiviral properties of 4 new medications in clinical trials

595 views • 45 slides

New Drugs and New Strategies from the 2014 CROI

New Drugs and New Strategies from the 2014 CROI. Jeffrey Lennox, MD Co-PI, Emory HIV/AIDS Clinical Trials Unit. Learning Objectives. After attending this presentation, learners will be able to:. Describe the antiviral properties of 4 new medications in clinical trials

549 views • 45 slides

Cost-Effectiveness in Medicine An Interactive Introduction

Cost-Effectiveness in Medicine An Interactive Introduction. Jan J. v. Busschbach, Ph.D. Erasmus MC Institute for Medical Psychology and Psychotherapy Viersprong Institute for studies on Personality Disorders Presentations can be found at: www.busschbach.nl. New cancer therapy.

454 views • 45 slides

Quality of life and Cost-Effectiveness An Interactive Introduction

453 views • 38 slides

Quality of life and Cost-Effectiveness An Interactive Introduction

383 views • 38 slides

Quality of life and Cost-Effectiveness An Interactive Introduction

Quality of life and Cost-Effectiveness An Interactive Introduction. Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong Institute for studies on Personality Disorders. New cancer therapy. Symptoms Drug X Drug Y Survival days 300 400

406 views • 33 slides

Interactive Introduction cost effectiveness

Interactive Introduction cost effectiveness. Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD) Jan.Busschbach@deviersprong.nl +31 164 632200 Department of Medical Psychology & Psychotherapy, Erasmus University Medical Center. New cancer therapy.

302 views • 19 slides

Study of Pulmonary Function Test in Type 2 Diabetics and COPD with Diabetes

Diabetes mellitus type 2 is a metabolic disorder that is characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency. This is typically a multi-organ chronic disease and is associated with a ten-year-shorter life expectancy due to its complications.

54 views • 5 slides

Introduction

114 views • 1 slides